Cargando…

The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism

BACKGROUND: Considering the high prevalence of congenital hypothyroidism (CH) in Isfahan and its different etiologies in comparison with other countries, the high rate of parental consanguinity, and the role of NIS gene in permanent CH due to dyshormonogenesis, the aim of this study was to investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Mostofizade, Neda, Nikpour, Parvaneh, Javanmard, Shaghayegh Haghjooy, Emadi-Baygi, Modjtaba, Miranzadeh-Mahabadi, Hajar, Hovsepian, Silva, Hashemipour, Mahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570912/
https://www.ncbi.nlm.nih.gov/pubmed/23412840
_version_ 1782259120788733952
author Mostofizade, Neda
Nikpour, Parvaneh
Javanmard, Shaghayegh Haghjooy
Emadi-Baygi, Modjtaba
Miranzadeh-Mahabadi, Hajar
Hovsepian, Silva
Hashemipour, Mahin
author_facet Mostofizade, Neda
Nikpour, Parvaneh
Javanmard, Shaghayegh Haghjooy
Emadi-Baygi, Modjtaba
Miranzadeh-Mahabadi, Hajar
Hovsepian, Silva
Hashemipour, Mahin
author_sort Mostofizade, Neda
collection PubMed
description BACKGROUND: Considering the high prevalence of congenital hypothyroidism (CH) in Isfahan and its different etiologies in comparison with other countries, the high rate of parental consanguinity, and the role of NIS gene in permanent CH due to dyshormonogenesis, the aim of this study was to investigate the G395R mutation of the NIS gene in patients with permanent CH due to dyshormonogenesis METHODS: In this case–control study, patients diagnosed with permanent CH due to dyshormonogenesis during CH screening program were selected. Venous blood sample was obtained to determine the G395R mutations of NIS gene using polymerase chain reaction (PCR) sequencing method. RESULTS: In this study, 35 CH patients with permanent CH due to dyshormonogenesis and 35 neonates with normal screening results as a control group were studied. We did not find any changes of the mentioned mutation of NIS gene in the patients’ group. CONCLUSION: Considering the findings of the current study, it seems that further studies with larger sample size and with consideration of other gene mutations such as pendrin and thyroglobulin are needed for more accurate conclusion.
format Online
Article
Text
id pubmed-3570912
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35709122013-02-14 The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism Mostofizade, Neda Nikpour, Parvaneh Javanmard, Shaghayegh Haghjooy Emadi-Baygi, Modjtaba Miranzadeh-Mahabadi, Hajar Hovsepian, Silva Hashemipour, Mahin Int J Prev Med Original Article BACKGROUND: Considering the high prevalence of congenital hypothyroidism (CH) in Isfahan and its different etiologies in comparison with other countries, the high rate of parental consanguinity, and the role of NIS gene in permanent CH due to dyshormonogenesis, the aim of this study was to investigate the G395R mutation of the NIS gene in patients with permanent CH due to dyshormonogenesis METHODS: In this case–control study, patients diagnosed with permanent CH due to dyshormonogenesis during CH screening program were selected. Venous blood sample was obtained to determine the G395R mutations of NIS gene using polymerase chain reaction (PCR) sequencing method. RESULTS: In this study, 35 CH patients with permanent CH due to dyshormonogenesis and 35 neonates with normal screening results as a control group were studied. We did not find any changes of the mentioned mutation of NIS gene in the patients’ group. CONCLUSION: Considering the findings of the current study, it seems that further studies with larger sample size and with consideration of other gene mutations such as pendrin and thyroglobulin are needed for more accurate conclusion. Medknow Publications & Media Pvt Ltd 2013-01 /pmc/articles/PMC3570912/ /pubmed/23412840 Text en Copyright: © International Journal of Preventive Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mostofizade, Neda
Nikpour, Parvaneh
Javanmard, Shaghayegh Haghjooy
Emadi-Baygi, Modjtaba
Miranzadeh-Mahabadi, Hajar
Hovsepian, Silva
Hashemipour, Mahin
The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism
title The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism
title_full The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism
title_fullStr The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism
title_full_unstemmed The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism
title_short The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism
title_sort g395r mutation of the sodium/iodide symporter (nis) gene in patients with dyshormonogenetic congenital hypothyroidism
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570912/
https://www.ncbi.nlm.nih.gov/pubmed/23412840
work_keys_str_mv AT mostofizadeneda theg395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT nikpourparvaneh theg395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT javanmardshaghayeghhaghjooy theg395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT emadibaygimodjtaba theg395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT miranzadehmahabadihajar theg395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT hovsepiansilva theg395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT hashemipourmahin theg395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT mostofizadeneda g395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT nikpourparvaneh g395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT javanmardshaghayeghhaghjooy g395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT emadibaygimodjtaba g395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT miranzadehmahabadihajar g395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT hovsepiansilva g395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism
AT hashemipourmahin g395rmutationofthesodiumiodidesymporternisgeneinpatientswithdyshormonogeneticcongenitalhypothyroidism